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P.029) and CHF (2.1% vs 0.6%; P.005). In multivar-
iate analysis, dextran was associated with a higher risk of
perioperative MI (OR, 5.2; CI,1.9-14.4; P.002) and
CHF (OR, 5.9; CI,1.9-18.5; P0.002).
Conclusions: Dextran use was not associated with
perioperative stroke but was associated with higher rates of
MI and CHF. Taken together, our findings suggest limited
clinical utility for dextran.
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Objectives: CMS requires high risk criteria for CAS
reimbursement. The impact of these criteria on outcomes
remains uncertain, potentially biasing comparative effec-
tiveness analysis. We evaluate this using data from the SVS
Vascular Registry™.
Methods: We analyzed 10,107 patients undergoing
CEA (6370) and CAS (3737). Patients were stratified by
CMS high risk (HR) criteria. The primary endpoint was
composite death, stroke and MI (MACE) at 30 days.
Results: CAS patients were more likely to have preop-
erative stroke (26 v 21%) or TIA (23 v 19%) than CEA.
While age 80years was similar, CAS had higher preva-
lence of all other HR criteria. For CEA, HR patients had
higher MACE than normal risk: SX (7.3 v 4.6%, P.01)
and ASX (5 vs 2.2%; P.0001). For CAS there was no
difference: SX (9.1 vs 6.2%; P.24) or ASX (5.4 vs 4.2%;
P.61) All CAS patients had MACE rates similar to HR
CEA. After risk adjustment, CAS had higher rates than
CEA for MACE (OR, 1.2; 95%CI, 1.0-1.5), death (1.5,
1.0-2.2) and stroke (1.3, 1.0-1.7), while there was no
difference in MI (OR, 0.8, 0.6-1.3). Multivariate analyses
for predictors of MACE are reported in the Table. Radia-
tion and restenosis were protective for MACE from CAS.
Conclusions: CEA is safer in the majority of patients
with carotid disease. Normal risk CAS may be confined to
restenosis and radiation.
Table. Multivariate logistic models for 30-day MACE
CEA - Risk factors
Odds
ratio 95% CI P value
Symptomatic 1.831 1.426-2.351 .0001
Age 80y 1.370 1.024-1.833 .0341
CHF class III/IV 1.707 1.027-2.839 .0392
LVEF 30% 3.529 1.620-7.690 .0015
Angina 3.920 1.545-9.942 .0040
Contralateral occlusion 3.164 2.112-4.738 .0001
High anatomic lesion 2.723 1.321-5.616 .0067
CAS - Risk factors
Odds
ratio 95% CI P value
Symptomatic 1.674 1.292-2.170 .0001
Recent MI 3.433 1.674-7.043 .0008
Restenosis 0.591 0.430-0.813 .0012
Prior radiation to neck 0.418 0.225-0.776 .0057
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Table.
Characteristics
Crude sample Group matched sample Propensity matched sample
Dextran, %
(n443)
No Dextran, %
(n6397) P value
Dextran, %
(n333)
No Dextran, %
(n1523) P value
Dextran, %
(n334)
No Dextran, %
(n1670) P value
General
Anesthesia
74.3 88.9 .001 74.5 79.3 0.06 74.3 73.5 .84
Eversion 19.2 10.0 .001 19.2 24.7 0.03 19.2 19.2 .99
Shunt 18.9 48.6 .001 18.9 20.1 0.65 18.9 23.2 .10
Outcomes
Stroke or death 1.2 1.0 .58 1.2 0.6 0.27 1.2 0.7 .32
MI 2.4 1.0 .03 2.4 0.6 0.005 2.4 0.5 .003
CHF 2.1 0.6 .005 2.1 0.5 0.006 2.1 0.2 .001
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Objectives: Carotid angioplasty and stenting (CAS)
has been proposed as alternative to carotid endarterectomy
(CEA), but late outcomes are unknown. Late outcomes
after CEA have not been examined in a contemporary series
and such is the aim of the current study.
Methods: This was a retrospective study of patients
who had undergone CEA at a single institution between
01/01/1989 and 12/01/2005. Primary study end points
were stroke and death. Secondary study end points were
recurrent stenosis and reintervention. Kaplan-Meir analysis
was used to create survival curves for the study end points.
Multivariate models were created to identify variables asso-
ciated with the study end points.
Results: A total of 3308 CEAs (mean age 71.1  8.9
years; 60.4% male; 31.3% symptomatic; 3.5% redo surgery;
49.2% primary closure) were performed during the study
period with mean follow up of 5.1 years [0-21.9 years].
Thirty-day stroke and death rates were 2.0% (1.2% ipsilat-
eral) and 1.3% (inclusive of CEA/CABG), respectively.
Median survival was 8.2 years with 5, 10, and 15-year
survival of 70%, 42%, and 19%, respectively. Five, 10, and
15-year (any) stroke-free survival were 93%, 85%, and 72%,
respectively. Cox proportional hazards analysis showed di-
abetes (HR1.90; P.0001), coronary artery disease
(HR1.75; P.0001), chronic obstructive pulmonary dis-
ease (HR1.60; P.0002), current smoking status
(HR1.41; P.0011), male gender (HR1.20; P.04),
and age at CEA (HR1.07; P.0001) to be predictive of
death. Symptomatic disease (HR1.83; P.0001), diabe-
tes (HR1.75; P.0004), and female gender (HR1.61;
P.0013) were predictive of late stroke. Restenosis(mod-
erate or severe)-free survival at 5, 10, and 15 years were
77%, 64%, and 47%, respectively, whereas reintervention-
free survival at 5, 10, and 15 years were 97%, 93%, and 89%,
respectively.
Conclusions: CEA is associated with favorable long-
term clinical and anatomic outcomes. These data may serve
as a standard to compare late outcomes of CAS.
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Objectives: Administrative data (AD) have been used to
compare CEA and CAS. However, there are limitations in
defining prior stroke/TIA and complications thatmay vary by
procedure. Therefore, we did a direct comparison between
administrative data and MD chart review for CEA and CAS.
Methods: We performed an outcomes analysis on all
CEA and CAS procedures from 2005-2010. We obtained
ICD-9 codes from hospital records regarding prior stroke/
TIA, symptom and high-risk status, and complications. An
MD performed a chart review of the same patient records
and the results were compared.
Results: We identified 983 patients: 876 CEA and 107
CAS. Prior stroke/TIA (6 months old) was overesti-
mated with AD (8.5% vs 5.9%) while the proportion of
symptomatic patients was grossly underestimated (8.4% vs
31.6%). Physiologic high-risk status was also underesti-
mated (5.0% vs 9.1%), but individual physiologic high-risk
variables were overestimated. Anatomic high-risk status
was unable to be determined with AD. The identification of
perioperative strokes was identical at 2.1%, but with AD
there were 6 false positive strokes and 6 false negative
strokes identified giving an accuracy of 56%.
Conclusions: Administrative data are useful, but sub-
ject to coding accuracy. Administrative data are unreliable
for determining preoperative symptom status and postop-
erative stroke complications when analyzing outcomes of
CEA and CAS.
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Table. Comparison of outcomes analysis using administrative data versus MD chart review in patients who have
undergone CEA or CAS
Administrative
data
MD chart
review Administrative data
MD chart
review
Prior stroke/TIA 8.5% 5.9% Physiologic high-risk 5.0% 9.1%
Symptomatic 8.4% 31.6% Age  80 19.3% 19.3%
Anatomic high-risk 0% 4.8% MI within 30 days 12.6% 0.2%
Stroke complicationsa 2.1% 2.1% Unstable angina 0.1% 1.0%
True positive strokes 15 (71.4%) 21 CHF class III/IV 9.3% 0.3%
False positive strokes 6 (28.6%) 0 Hemodialysis 8.9% 1.1%
False negative strokes 6 (28.6%) 0 Pulmonary
dysfunction
16.7% 1.0%
aThe accuracy of identification of postoperative strokes with administrative data is 56%
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